Novo Nordisk invests more than DKK 17 bn in expansion of the manufacturing facilities in Kalundborg, Denmark Read more
European Commission Approves Pfizer’s Cibinqo (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis Read more
Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders Read more
Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th Annual 3D Cell Culture Conference Read more
Rapid Dose Therapeutics Signs Product Supply Agreement with Oakland Health Limited in the United Kingdom Read more
Syndax Pharmaceuticals Announces Closing of Global Collaboration and License Agreement for Axatilimab Read more
Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia Read more
Evusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19 Read more
Brii Bio Announces Amubarvimab/Romlusevimab Combination Received Approval from NMPA as First COVID-19 Neutralizing Antibody Combination Therapy in China Read more